Demcizumab (Anti-DLL4)

Ask supplier a question | View on supplier's website

Demcizumab (Anti-DLL4) is a monoclonal antibody taregting DLL4. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models. MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2520
Sku #	A2520-1mg
Pricing	1mg, $470.00

Feedback